BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24885453)

  • 1. Estimating age-based antiretroviral therapy costs for HIV-infected children in resource-limited settings based on World Health Organization weight-based dosing recommendations.
    Doherty K; Essajee S; Penazzato M; Holmes C; Resch S; Ciaranello A
    BMC Health Serv Res; 2014 May; 14():201. PubMed ID: 24885453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costing analysis of national HIV treatment and care program in Vietnam.
    Duong AT; Kato M; Bales S; Do NT; Minh Nguyen TT; Thanh Cao TT; Nguyen LT
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):e1-7. PubMed ID: 23846564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.
    Weidle PJ; Abrams EJ; Gvetadze R; Rivadeneira E; Kline MW
    Pediatr Infect Dis J; 2006 Jan; 25(1):59-64. PubMed ID: 16395105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of weekends-off antiretroviral therapy for young people in 11 countries.
    Tierrablanca LE; Ochalek J; Ford D; Babiker A; Gibb D; Butler K; Turkova A; Griffin S; Revill P;
    Medicine (Baltimore); 2018 Feb; 97(5):e9698. PubMed ID: 29384848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-efficacy comparison among three antiretroviral regimens in HIV-1 infected, treatment-experienced patients.
    Ruof J; Dusek A; DeSpirito M; Demasi RA
    Clin Drug Investig; 2007; 27(7):469-79. PubMed ID: 17563127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The next generation of the World Health Organization's global antiretroviral guidance.
    Hirnschall G; Harries AD; Easterbrook PJ; Doherty MC; Ball A
    J Int AIDS Soc; 2013 Jun; 16(1):18757. PubMed ID: 23819908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
    Lapphra K; Vanprapar N; Chearskul S; Phongsamart W; Chearskul P; Prasitsuebsai W; Chokephaibulkit K
    Int J Infect Dis; 2008 Nov; 12(6):e33-8. PubMed ID: 18573672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of weight-based prescription of antiretroviral therapy in children.
    Dakshina S; Olaru ID; Khan P; Raman L; McHugh G; Bwakura-Dangarembizi M; Nathoo K; Munyati S; Mujuru H; Ferrand RA
    HIV Med; 2019 Mar; 20(3):248-253. PubMed ID: 30632659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nevirapine exposure with WHO pediatric weight band dosing: enhanced therapeutic concentrations predicted based on extensive international pharmacokinetic experience.
    Nikanjam M; Kabamba D; Cressey TR; Burger D; Aweeka FT; Acosta EP; Spector SA; Capparelli EV
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5374-80. PubMed ID: 22869579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral Stewardship in a Pediatric HIV Clinic: Development, Implementation and Improved Clinical Outcomes.
    Hsu AJ; Neptune A; Adams C; Hutton N; Agwu AL
    Pediatr Infect Dis J; 2016 Jun; 35(6):642-8. PubMed ID: 26906161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness of initial adherence to antiretroviral therapy among HIV infected patients in Belo Horizonte, Brazil].
    Acurcio Fde A; Puig-Junoy J; Bonolo Pde F; Braga Ceccato Md; Guimarães MD
    Rev Esp Salud Publica; 2006; 80(1):41-54. PubMed ID: 16553259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a significant reduction in malaria risk make lopinavir/ritonavir-based ART cost-effective for children with HIV in co-endemic, low-resource settings?
    Ahmed BS; Phelps BR; Reuben EB; Ferris RE
    Trans R Soc Trop Med Hyg; 2014 Jan; 108(1):49-54. PubMed ID: 24300443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economics of switching to second-line antiretroviral therapy with lopinavir/ritonavir in Africa: estimates based on DART trial results and costs for Uganda and Kenya.
    Simpson KN; Baran RW; Kirbach SE; Dietz B
    Value Health; 2011 Dec; 14(8):1048-54. PubMed ID: 22152173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV treatment and care in resource-constrained environments: challenges for the next decade.
    Eholié SP; Aoussi FE; Ouattara IS; Bissagnéné E; Anglaret X
    J Int AIDS Soc; 2012 Aug; 15(2):17334. PubMed ID: 22944479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
    Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
    PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis.
    Walensky RP; Wood R; Ciaranello AL; Paltiel AD; Lorenzana SB; Anglaret X; Stoler AW; Freedberg KA;
    PLoS Med; 2010 Dec; 7(12):e1000382. PubMed ID: 21209794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children.
    Waning B; Diedrichsen E; Jambert E; Bärnighausen T; Li Y; Pouw M; Moon S
    BMC Pediatr; 2010 Oct; 10():74. PubMed ID: 20950492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of first-line antiretroviral therapy for HIV-infected African children less than 3 years of age.
    Ciaranello AL; Doherty K; Penazzato M; Lindsey JC; Harrison L; Kelly K; Walensky RP; Essajee S; Losina E; Muhe L; Wools-Kaloustian K; Ayaya S; Weinstein MC; Palumbo P; Freedberg KA
    AIDS; 2015 Jun; 29(10):1247-59. PubMed ID: 25870982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.